rrx-001 Report issue

Small molecule Experimental
AACT DrugBank PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: O=C(CBr)N1CC([N+](=O)[O-])([N+](=O)[O-])C1
  • InChIKey: JODKFOVZURLVTG-UHFFFAOYSA-N
  • Mol. Mass: 268.02
  • ALogP: -0.53
  • ChEMBL Molecule:
    rrx-001  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

rrx-001

Organizations (8)

Research & Development (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Brain Neoplasms (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Small Cell (Phase 2)

Central Nervous System Neoplasms (Phase 1)

Cholangiocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 2)

Glioblastoma (Phase 1)

Lymphoma (Phase 1)

Neoplasms (Phase 1)

Neuroendocrine Tumors (Phase 2)

Oligodendroglioma (Phase 1)

Small Cell Lung Carcinoma (Phase 3)

Stomatitis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 14
  • # of Trial Organizations: 8

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue